(BRNL) Brunel International - Ratings and Ratios
Secondment, Recruitment, Consulting, Mobility, Project
Dividends
| Dividend Yield | 7.04% |
| Yield on Cost 5y | 8.87% |
| Yield CAGR 5y | 22.39% |
| Payout Consistency | 76.8% |
| Payout Ratio | 3.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.2% |
| Value at Risk 5%th | 36.4% |
| Relative Tail Risk | -12.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -13.17 |
| CAGR/Max DD | -0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.535 |
| Beta | 0.137 |
| Beta Downside | 0.197 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.23% |
| Mean DD | 19.09% |
| Median DD | 21.99% |
Description: BRNL Brunel International October 25, 2025
Brunel International N.V. (AS: BRNL) is a Dutch-based provider of talent-and-project solutions, operating across Europe, Australasia, the Middle East, India, the Americas and other global markets. Founded in 1975 and headquartered in Amsterdam, the firm is listed under the GICS sub-industry “Human Resource & Employment Services.”
The company’s offering spans three pillars: (1) project and consultancy services-including performance management, risk assurance, third-party vendor inspection, commissioning, operational readiness and dedicated project management offices; (2) workforce solutions such as contract and permanent staffing, recruitment process outsourcing, executive search, secondments, training, employee care and market-intelligence benchmarking; and (3) global mobility services covering relocation, employer-of-record, immigration, destination assistance, medical repatriation, security management and travel-logistics support.
Brunel serves high-growth sectors-life sciences, renewable and conventional energy, infrastructure, future mobility and mining-where labor shortages and regulatory pressure are intensifying demand for flexible, skilled talent. In FY 2023 the firm reported €1.1 bn of revenue, with a 9 % YoY increase driven largely by a 15 % rise in renewable-energy project contracts, while its EBITDA margin hovered around 6 % despite elevated inflation-related cost pressures. The broader HR-services market is expanding at a 5-6 % CAGR, underpinned by the EU’s “green transition” funding pipeline and the persistent skills gap in engineering and scientific roles.
For a deeper, data-driven assessment of Brunel’s valuation and risk profile, you may find ValueRay’s analytical platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (54.8m TTM) > 0 and > 6% of Revenue (6% = 137.4m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 7.49pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.27% (prev 21.29%; Δ -10.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 74.6m > Net Income 54.8m (YES >=105%, WARN >=100%) |
| Net Debt (12.1m) to EBITDA (143.4m) ratio: 0.08 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (50.3m) change vs 12m ago -0.14% (target <= -2.0% for YES) |
| Gross Margin 31.16% (prev 38.58%; Δ -7.42pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 396.5% (prev 218.9%; Δ 177.6pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.43 (EBITDA TTM 143.4m / Interest Expense TTM 8.24m) >= 6 (WARN >= 3) |
Altman Z'' 4.40
| (A) 0.47 = (Total Current Assets 409.1m - Total Current Liabilities 150.9m) / Total Assets 544.1m |
| (B) 0.00 = Retained Earnings (Balance) 304.0k / Total Assets 544.1m |
| (C) 0.19 = EBIT TTM 110.6m / Avg Total Assets 577.7m |
| (D) 0.00 = Book Value of Equity 304.0k / Total Liabilities 274.1m |
| Total Rating: 4.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.66
| 1. Piotroski 7.50pt |
| 2. FCF Yield 10.70% |
| 3. FCF Margin 1.49% |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 0.08 |
| 6. ROIC - WACC (= 11.43)% |
| 7. RoE 18.52% |
| 8. Rev. Trend 31.08% |
| 9. EPS Trend -41.55% |
What is the price of BRNL shares?
Over the past week, the price has changed by -2.50%, over one month by +3.03%, over three months by -5.90% and over the past year by -6.98%.
Is BRNL a buy, sell or hold?
What are the forecasts/targets for the BRNL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.3 | 5.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 8.4 | 7.7% |
BRNL Fundamental Data Overview November 26, 2025
Market Cap EUR = 393.6m (393.6m EUR * 1.0 EUR.EUR)
P/E Trailing = 26.0667
P/E Forward = 15.2207
P/S = 0.306
P/B = 1.4753
P/EG = 1.99
Beta = 0.501
Revenue TTM = 2.29b EUR
EBIT TTM = 110.6m EUR
EBITDA TTM = 143.4m EUR
Long Term Debt = 87.5m EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = 12.1m EUR (from netDebt column, last quarter)
Enterprise Value = 318.2m EUR (393.6m + (null Debt) - CCE 75.4m)
Interest Coverage Ratio = 13.43 (Ebit TTM 110.6m / Interest Expense TTM 8.24m)
FCF Yield = 10.70% (FCF TTM 34.0m / Enterprise Value 318.2m)
FCF Margin = 1.49% (FCF TTM 34.0m / Revenue TTM 2.29b)
Net Margin = 2.39% (Net Income TTM 54.8m / Revenue TTM 2.29b)
Gross Margin = 31.16% ((Revenue TTM 2.29b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Gross Margin QoQ = 18.68% (prev 100.0%)
Tobins Q-Ratio = 0.58 (Enterprise Value 318.2m / Total Assets 544.1m)
Interest Expense / Debt = unknown (Interest Expense 4.18m / Debt none)
Taxrate = 38.24% (9.69m / 25.3m)
NOPAT = 68.3m (EBIT 110.6m * (1 - 38.24%))
Current Ratio = 2.71 (Total Current Assets 409.1m / Total Current Liabilities 150.9m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 0.08 (Net Debt 12.1m / EBITDA 143.4m)
Debt / FCF = 0.36 (Net Debt 12.1m / FCF TTM 34.0m)
Total Stockholder Equity = 296.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.07% (Net Income 54.8m / Total Assets 544.1m)
RoE = 18.52% (Net Income TTM 54.8m / Total Stockholder Equity 296.0m)
RoCE = 28.85% (EBIT 110.6m / Capital Employed (Equity 296.0m + L.T.Debt 87.5m))
RoIC = 17.95% (NOPAT 68.3m / Invested Capital 380.7m)
WACC = 6.52% (E(393.6m)/V(393.6m) * Re(6.52%) + (debt-free company))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈34.0m ; Y1≈42.0m ; Y5≈71.7m
Fair Price DCF = 24.21 (DCF Value 1.22b / Shares Outstanding 50.3m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -41.55 | EPS CAGR: -45.10% | SUE: 0.0 | # QB: 0
Revenue Correlation: 31.08 | Revenue CAGR: 29.13% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=0.67 | Chg30d=-0.075 | Revisions Net=-2 | Growth EPS=+79.7% | Growth Revenue=+4.6%